Sandoz Ltd

Information

Name

Sandoz Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

http://www.sandoz.com

Address

Frimley Business Park, Frimley

Camberley
GU16 7SR
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Sandoz Ltd
Sign up free

Contracts awarded to Sandoz Ltd

The contracts that Sandoz Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 2 months ago

CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab

Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024 Offer reference number: CM/TNS/24/5711 CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£230,000,000 Bids close: 4 months ago
Award

Published 2 months ago

NHS National Framework for the supply of Ustekinumab - 1 September 2024

Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024 Offer reference number: CM/TNS/24/5711 CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£12
Award

Published 5 months ago

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£424,035,364 Bids close: 11 months ago
Award

Published 6 months ago

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 Offer reference number: CM/PHR/22/5682 CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028. CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Bids close: 11 months ago
Award

Published 6 months ago

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 Offer reference number: CM/PHR/22/5682 CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028. CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

£92
Award

Published 6 months ago

NHS National Framework for Transition products commencing 1 May 2024

Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months) CM/TNS/05/2024/02 - Apixaban, Sapropterin Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£7,559,000 Bids close: 7 months ago

Sandoz Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Sandoz Ltd

CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab

NHS National Framework for the supply of Ustekinumab - 1 September 2024

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS National Framework for Transition products commencing 1 May 2024

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win